Translate
Exicure, Inc.
About
2.67USD-0.14 -4.85%
Closed • Updated at 07:57 GMT+00:00Market Cap$17.04M
Volume6.3K
Beta-0.98
RSI31.12
Exicure, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Mar 25 2026
Exicure, Inc. Reports Full Year 2025 Financial Results
Feb 5 2026
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
Jan 21 2026
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Dec 8 2025
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
Recent Videos
How to Invest in Exicure Inc (XCUR) Step by Step
Mar 21, 2026
XCUR STOCK : FRESH MOMENTUM | EXICURE STOCK
Jan 11, 2026
FRESH MOMENTUM | XCUR STOCK ANALYSIS | EXICURE STOCK
Dec 13, 2025
Exicure Inc (XCUR) Stock Analysis | Price Surge & Market Update | Latest News Review
Dec 09, 2025
Community Chat
Ask AI
Try asking